Nutrition and Science Program of Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
Clin Nutr. 2022 Oct;41(10):2325-2332. doi: 10.1016/j.clnu.2022.08.022. Epub 2022 Aug 26.
BACKGROUND & AIMS: The Global Leadership Initiative on Malnutrition (GLIM) proposed a two-step approach for the malnutrition diagnosis: screening to identify "at risk" patients by any validated nutritional screening tool (NST), followed by a detailed nutritional assessment for diagnosis and grading the severity of malnutrition. Since there are several validated NST, this study aimed to evaluate the complementarity of five NST to GLIM criteria for malnutrition diagnosis in a sample of hospitalized patients.
A secondary analysis of a longitudinal study. Data collection occurred within 48 h of hospital admission and included clinical, sociodemographic and nutritional data. We applied five tools for nutritional risk (NR) screening: Malnutrition Screening Tool (MST), Malnutrition Universal Screening Tool (MUST), Nutritional Risk in Emergency-2017 (NRE-2017), Nutritional Risk Screening - 2002 (NRS-2002), and Short Nutritional Assessment Questionnaire (SNAQ). GLIM criteria were applied to malnutrition diagnosis considering all five criteria. Patients were followed up until discharge to assess hospital length of stay (LOS) and in-hospital mortality and contacted six months post-discharge to assess hospital readmission and death. We calculated the sensitivity, specificity, predictive positive and negative values (PPV and NPV), and kappa. We grouped patients according to NR and malnutrition status in four categories [i.e. NR(+)/GLIM(+)] and investigated their associations with the clinical outcomes in regression models adjusted to the Charlson Comorbidity Index.
Among the 601 patients included (55.8 ± 14.8 years, 51.4% males), 41.6% were malnourished by GLIM criteria. The frequency of NR ranged from 24.0% (NRE-2017) to 35.8% (NRS-2002). MUST had the highest sensitivity (73.6%), NPV (83.6%) and PPV (93.4%). All NST presented specificity higher than 90%, except NRS-2002. The accuracy of NST ranged from 76.3% (SNAQ) to 86.8% (MUST). NR (+)/GLIM (+) by NRE-2017, MST, and MUST increased the risk of in-hospital mortality (HR ranged from 5.34 to 10.10). NR (+)/GLIM (+) increased the odds of LOS ≥10 days (RR between 2.11 and 3.01), readmission (RR between 1.51 and 1.80), and mortality six months after discharge (RR between 3.91 and 5.12), regardless of the NST applied.
MUST presented the highest metrics of accuracy in comparison to GLIM criteria and was an independent predictor of worse clinical outcomes when nutritional risk was combined to malnutrition diagnosis. So, risk screening by MUST is suggested as the first step of the GLIM approach.
全球营养不良领导倡议(GLIM)提出了一种两步法来进行营养不良诊断:通过任何经过验证的营养筛查工具(NST)进行筛查,以识别“有风险”的患者,然后进行详细的营养评估以诊断和分级营养不良的严重程度。由于有多种经过验证的 NST,本研究旨在评估五种 NST 与 GLIM 营养不良诊断标准在住院患者样本中的互补性。
这是一项纵向研究的二次分析。数据收集在入院后 48 小时内进行,包括临床、社会人口学和营养数据。我们应用了五种营养风险(NR)筛查工具:营养不良筛查工具(MST)、营养不良通用筛查工具(MUST)、紧急情况营养风险-2017(NRE-2017)、营养风险筛查-2002(NRS-2002)和简短营养评估问卷(SNAQ)。根据所有五项标准应用 GLIM 标准进行营养不良诊断。对患者进行随访,直到出院,以评估住院时间(LOS)和院内死亡率,并在出院后六个月联系患者,以评估再次住院和死亡情况。我们计算了灵敏度、特异性、预测阳性和阴性值(PPV 和 NPV)以及kappa。我们根据 NR 和营养不良状态将患者分为四类[即 NR(+)/GLIM(+)],并在调整 Charlson 合并症指数的回归模型中研究了它们与临床结局的关系。
在纳入的 601 名患者中(55.8±14.8 岁,51.4%为男性),41.6%根据 GLIM 标准存在营养不良。NR 的频率范围为 24.0%(NRE-2017)至 35.8%(NRS-2002)。MUST 的灵敏度最高(73.6%),NPV(83.6%)和 PPV(93.4%)最高。除了 NRS-2002 外,所有 NST 的特异性均高于 90%。NST 的准确性范围为 76.3%(SNAQ)至 86.8%(MUST)。NRE-2017、MST 和 MUST 检测到的 NR(+)/GLIM(+)增加了院内死亡率的风险(HR 范围为 5.34 至 10.10)。NR(+)/GLIM(+)增加了 LOS≥10 天(RR 范围为 2.11 至 3.01)、再次住院(RR 范围为 1.51 至 1.80)和出院后 6 个月死亡(RR 范围为 3.91 至 5.12)的风险,无论应用何种 NST。
与 GLIM 标准相比,MUST 的准确性指标最高,当营养风险与营养不良诊断相结合时,它是更差临床结局的独立预测因素。因此,建议使用 MUST 进行风险筛查作为 GLIM 方法的第一步。